243
Views
15
CrossRef citations to date
0
Altmetric
SALIVARY GLANDS

OK-432 treatment of ranula extending to the parapharyngeal space

, , , , &
Pages 206-210 | Received 29 Jul 2013, Accepted 08 Sep 2013, Published online: 21 Nov 2013

References

  • Patel MR, Deal AM, Shockley WW. Oral and plunging ranula: what is the most effective treatment? Laryngoscope 2009;119:1501–9.
  • Lee HM, Lim HW, Kang HJ, Chae SW, Hwang SJ, Jung KY, et al. Treatment of ranula in pediatric patients with intralesional injection of OK-432. Laryngoscope 2006;116:966–9.
  • Woo JS, Hwang SJ, Lee HM. Recurrent plunging ranula treated with OK-432. Eur Arch Otorhinolaryngol 2003;260:226–8.
  • Kinoshita M, Kida W, Nakahara H. Plunging ranula intruding into the parapharyngeal space treated with OK-432. Am J Otolaryngol 2012;33:345–8.
  • Ohta N, Fukase S, Suzuki Y, Ishida A, Aoyagi M. Treatment of various otolaryngological cystic diseases by OK-432: its indications and limitations. Laryngoscope 2010;120:2193–6.
  • Ohta N, Fukase S, Watanabe T, Ito T, Aoyagi M. Effects and mechanism of OK-432 therapy in various neck cystic lesions. Acta Otolaryngol 2010;130:1287–92.
  • Fukase S, Ohta N, Inamura K, Aoyagi M. Treatment of ranula with intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol 2003;112:214–20.
  • Tsuchiya I, Kasahara T, Yamashita K, Ko YC, Kanazawa K, Matsushima K, et al. Induction of inflammatory cytokines in the pleural effusion of cancer patients after the administration of an immunomodulator, OK-432: role of IL-8 for neutrophil infiltration. Cytokine 1993;5:595–603.
  • Kitsuki H, Katano M, Ikubo A, Morisaki T, Anann K, Tanaka M, et al. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-γ in enhancement of surface expression of ICAM-1 on tumor cells in vivo. Clin Immunol Immunopathol 1996;78:283–90.
  • Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987;74:690–1.
  • Ohta N, Fukase S, Watanabe T, Ito T, Kubota T, Suzuki Y, et al. Treatment of thyroglossal duct cysts by OK-432. Laryngoscope 2012;122:131–3.
  • Ohta N, Fukase S, Suzuki Y, Aoyagi M. Treatment of salivary mucocele of the lower lip by OK-432. Auris Nasus Larynx 2011;38:240–3.
  • Fukase Y, Fukase S, Sendo F. Priming activity for chemiluminescence reaction of PMN in the culture supernatant of streptococcal preparation (OK-432)-stimulated spleen cells. Microbiol Immunol 1988;32:621–33.
  • Roh JL, Sung MW, Hyun Kim K, Il Park C. Treatment of branchial cleft cyst with intralesional injection of OK-432. Acta Otolaryngol 2006;126:510–14.
  • Sung MW, Lee DW, Kim DY, Lee SJ, Hwang CH, Park SW, et al. Sclerotherapy with Picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001;111:1430–3.
  • Kubota T, Ohta N, Fukase S, Kon Y, Aoyagi M. Treatment of auricular hematoma by OK-432. Otolaryngol Head Neck Surg 2010;142:863–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.